ロード中...
Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
BACKGROUND: Transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (HCC) is often repeated until unTACEable progression (UTP) occurs. There is little data on the various reasons for stopping TACE and its consequences for subsequent treatment and survival. AIM: To asse...
保存先:
| 出版年: | Cardiovasc Intervent Radiol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344387/ https://ncbi.nlm.nih.gov/pubmed/30488302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00270-018-2118-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|